Hologic CE marks Pap slide imaging system
This article was originally published in Clinica
Hologic has CE marked its ThinPrep integrated imager for sale in Europe to aid in the diagnosis of cervical cancer. The device is designed to analyse ThinPrep Pap test slide in around 90 seconds, during which time each cell and cell cluster is scanned. Using optical density analysis, the system identifies diagnostically-relevant cells or cell groups and presents the resulting data to the cytotechnologist for interpretation. If no abnormalities are identified, the slide can be marked as negative or put through the laboratory's quality control system. A complete slide review is required if any suspicious cells are detected; this dual review process combines human interpretative expertise with the power of computer imaging, claims Bedford, Massachusetts-based Hologic.
You may also be interested in...
Dr Noam Emanuel is the founder and chief technology officer of Ness Ziona, Israel-based drug delivery firm PolyPid. The 15-strong firm, established in 2008, has developed an encapsulation technology which allows the precise targeting of drug release.
Mesoblast has received the all-clear from the US FDA to start a Phase III clinical trial for bone marrow regeneration in patients with blood cancers. The study will be conducted together with Mesoblast's strategic alliance partner, Cephalon, which will fund the trial.
Mesoblast has received the green light from the US FDA to begin a Phase II trial of its proprietary adult mesenchymal precursor cell (MPC) product for the treatment of degenerative disc disease, a major cause of chronic low back pain.